A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Navane Indications, Dosage, Storage, Stability - Thiothixene Hcl
Navane Indications, Dosage, Storage, Stability - Thiothixene Hcl
INDICATIONS AND USAGE
Navane is effective in the management of schizophrenia. Navane has not been evaluated in the management of behavioral complications in patients with mental retardation.
DOSAGE AND ADMINISTRATION
Dosage of Navane should be individually adjusted depending on the chronicity and severity of the symptoms of schizophrenia. In general, small doses should be used initially and gradually increased to the optimal effective level, based on patient response.
Some patients have been successfully maintained on once-a-day Navane therapy.
The use of Navane in children under 12 years of age is not recommended because safe conditions for its use have not been established.
In milder conditions, an initial dose of 2 mg three times daily. If indicated, a subsequent increase to 15 mg/day total daily dose is often effective.
In more severe conditions, an initial dose of 5 mg twice daily.
The usual optimal dose is 20 to 30 mg daily. If indicated, an increase to 60 mg/day total daily dose is often effective. Exceeding a total daily dose of 60 mg rarely increases the beneficial response.
HOW SUPPLIED
Navane® (thiothixene) Capsules
Bottles of 100’s: 1 mg (NDC 0049-5710-66)
2 mg (NDC 0049-5720-66)
5 mg (NDC 0049-5730-66)
10 mg (NDC 0049-5740-66)
20 mg (NDC 0049-5770-66)
Ó 2001 PFIZER INC
Roerig, Division of Pfizer Inc, NY, NY 10017, Printed in U.S.A. 69-1655-00-9, Revised May 2001
top
